期刊文献+

肥胖对哮喘儿童治疗效果及肺功能的影响 被引量:16

Impact of obesity on response to therapy and pulmonary function in children with asthma
原文传递
导出
摘要 目的探讨肥胖对哮喘患儿规范化吸入疗法疗效及肺功能的影响。方法 129例哮喘患儿分为正常体重哮喘组(n=64)和哮喘伴肥胖组(n=65),比较两组患儿接受规范化吸入治疗1年后的肺功能和哮喘控制情况,其中肺功能采用第1秒用力呼气容积占预计值的百分比(FEV1%)、用力肺活量占预计值百分比(FVC%)、呼气峰流速(PEF)、用力呼气25%流速(PEF_(25))、用力呼气50%流速(PEF_(50))表示。另选取68例健康儿童作为健康对照组。结果治疗前3组间肺功能各指标比较差异均有统计学意义(P<0.01),其中健康对照组肺功能测定值最优,哮喘伴肥胖组测定值最差。治疗1年后正常体重哮喘组FEV1%、FVC%的改善均明显优于哮喘伴肥胖组(P<0.01),但两组间PEF、PEF_(25)、PEF_(50)的改善差异无统计学意义。治疗1年后,正常体重哮喘组哮喘完全控制率、部分控制率、未控制率分别为72%、19%、9%;哮喘伴肥胖组完全控制率、部分控制率、未控制率分别为28%、51%、22%,正常体重哮喘组哮喘控制率优于哮喘伴肥胖组(P<0.01)。结论哮喘伴肥胖患儿治疗后大气道功能改善及哮喘控制状况较正常体重哮喘患儿差。 Objective To investigate the effects of obesity on response to therapy and pulmonary function in children with asthma who receive inhaled corticosteroid(ICS) treatment. Methods A total of 129 children with asthma were divided into two groups according to their body mass index: normal weight group(n=64) and obese group(n=65). The asthma control status and pulmonary function were compared between the two groups after one year of ICS treatment. The pulmonary function was expressed as percent forced expiratory volume in 1 second(FEV1%), percent predicted forced vital capacity(FVC%), peak expiratory flow(PEF), peak expiratory flow at 25% of vital capacity(PEF_(25)), and peak expiratory flow at 50% of vital capacity(PEF_(50)). The asthma control status was expressed as complete control rate, partial control rate, and uncontrolled rate. Sixty-eight healthy children were selected as the healthy control group. Results There were significant differences in the indices of pulmonary function between the three groups before treatment(P0.01); the healthy control group had the best values of pulmonary function, while the obese group had the worst values. After 1 year of treatment, the normal weight group showed significantly more improvements in FEV1% and FVC% than the obese group(P0.01). However, there were no significant differences in improvements in PEF, PEF_(25), and PEF_(50) between the two groups. The complete control rate, partial control rate, and uncontrolled rate in the normal weight group were 72%, 19%, and 9%, respectively, while the rates in the obese group were 28%, 51%, and 22%, respectively; the normal weight group had a significantly better asthma control status than the obese group(P0.01). Conclusions The asthmatic children with obesity have a significantly less improvement in large airway function and a poorer asthma control status after ICS treatment than those with the normal weight.
作者 王婧 潘家华
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2016年第1期55-60,共6页 Chinese Journal of Contemporary Pediatrics
关键词 哮喘 肥胖 治疗效果 肺功能 儿童 Asthma Obesity Response to therapy Pulmonary function Child
  • 相关文献

参考文献3

二级参考文献22

  • 1Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol, 2005,115 : 897-909 : quiz 910.
  • 2Sin DD, Jones RL, Man SF. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med, 2002,162 : 1477-1481.
  • 3Shore SA, Johnston RA. Obesity and asthma. Pharmacol Ther, 2006,110 : 83-102.
  • 4Aaron SD, Fergusson D, Dent R, et al. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest, 2004,125 : 2046-2052.
  • 5Keaney JF Jr, Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress:clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol, 2003,23 : 434-439.
  • 6Cho YS, Moon HB. The role of oxidative stress in the pathogenesis of asthma. Allergy Asthma Immunol Res,2010, 2:183-187.
  • 7Holguin F, Fitzpatrick A. Obesity, asthma, and oxidative stress. J Appl Pbysiol, 2010,108 : 754-759.
  • 8Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun, 2006,7:95-100.
  • 9Rankinen T, Zuberi A, Chagnon YC, et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring), 2006,14:529-644.
  • 10Shore SA, Terry RD, Flynt L, et al. Adiponectin attenuates allergen-induced airway inflammation and hyperres- ponsiveness in mice. J Allergy Clin Immunol, 2006,118 :389-395.

共引文献2520

同被引文献113

引证文献16

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部